Marpai, Inc. Files 8-K: Material Agreement & Equity Sales
Ticker: MRAI · Form: 8-K · Filed: Sep 3, 2024 · CIK: 1844392
| Field | Detail |
|---|---|
| Company | Marpai, INC. (MRAI) |
| Form Type | 8-K |
| Filed Date | Sep 3, 2024 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.0001, $0.481 |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-agreement, equity-sale, financials
TL;DR
Marpai filed an 8-K on 8/28 for a new material deal and equity sales.
AI Summary
On August 28, 2024, Marpai, Inc. entered into a material definitive agreement. The company also reported on unregistered sales of equity securities and filed financial statements and exhibits. The exact nature of the agreement and the details of the equity sales are not specified in this filing.
Why It Matters
This filing indicates significant corporate activity for Marpai, Inc., including a new material agreement and equity transactions, which could impact its financial standing and future operations.
Risk Assessment
Risk Level: medium — The filing mentions a material definitive agreement and unregistered sales of equity securities, which can introduce financial and operational risks if not managed properly.
Key Players & Entities
- Marpai, Inc. (company) — Registrant
- August 28, 2024 (date) — Date of earliest event reported
FAQ
What is the nature of the material definitive agreement entered into by Marpai, Inc. on August 28, 2024?
The filing states that Marpai, Inc. entered into a material definitive agreement on August 28, 2024, but the specific details of this agreement are not provided in the provided text.
What type of equity securities were sold by Marpai, Inc. under the unregistered sales provision?
The filing mentions unregistered sales of equity securities by Marpai, Inc., but the specific type or amount of securities sold is not detailed in the provided text.
What are the key financial statements and exhibits being filed by Marpai, Inc. with this 8-K?
The filing indicates that financial statements and exhibits are being filed, but the specific content of these documents is not described in the provided text.
What is Marpai, Inc.'s principal executive office address?
Marpai, Inc.'s principal executive offices are located at 615 Channelside Drive, Suite 207, Tampa, Florida 33602.
Under which section of the Securities Exchange Act of 1934 is this 8-K report filed?
This 8-K report is filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
Filing Stats: 698 words · 3 min read · ~2 pages · Grade level 13 · Accepted 2024-09-03 16:33:08
Key Financial Figures
- $0.0001 — tered Class A Common Stock, par value $0.0001 per share MRAI OTCQX Market Indic
- $0.481 — ivate placement, at a purchase price of $0.481 per share (or the closing bid price of
Filing Documents
- ea0213325-8k_marpai.htm (8-K) — 37KB
- ea021332501ex10-1_marpai.htm (EX-10.1) — 108KB
- 0001213900-24-075117.txt ( ) — 342KB
- mrai-20240828.xsd (EX-101.SCH) — 3KB
- mrai-20240828_lab.xml (EX-101.LAB) — 33KB
- mrai-20240828_pre.xml (EX-101.PRE) — 22KB
- ea0213325-8k_marpai_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. MARPAI, INC. Date: September 3, 2024 By: /s/ Damien Lamendola Name: Damien Lamendola Title: Chief Executive Officer 2